CDCA1 peptide and pharmaceutical agent comprising the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8598125
APP PUB NO 20110152199A1
SERIAL NO

12673434

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides the peptide of (A) or (B) below, and methods of using the peptide:

    (A) a peptide including the amino acid sequence of SEQ ID NO: 1 or 2,(B) a peptide which includes the amino acid sequence of SEQ ID NO: 1 or 2, wherein one, two, or several amino acid(s) are substituted, deleted, inserted, and/or added, and wherein the peptide shows killer T cell-inducing activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONCOTHERAPY SCIENCE INCKAWASAKI-SHI KANAGAWA 213-0012

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Harao, Michiko Kumamoto, JP 2 12
Nakamura, Yusuke Tokyo, JP 416 3218
Nishimura, Yasuharu Kumamoto, JP 27 150
Tsunoda, Takuya Kanagawa, JP 101 492

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00